189 filings
Page 2 of 10
8-K
f4ub0bm
8 May 23
Marker Therapeutics Appoints Monic Stuart, M.D., as Chief Medical Officer
7:45am
8-K
4vd9qmvq1bt rp2t905d
1 May 23
MaRKER Announces LeADERSHIP TRANSITIONÂ & ProVIdes UPDATE ON OPERATIONAL STRATEGY
7:36am
8-K
079cxjd13lhzjulkek
22 Mar 23
Marker Therapeutics Reports Fiscal Year 2022 Corporate and Financial Results
8:18am
8-K
h37k1ya57m2pk4770
16 Mar 23
Departure of Directors or Certain Officers
4:05pm
8-K
7kfakazjkem8 92yi
26 Jan 23
Amendments to Articles of Incorporation or Bylaws
4:16pm
8-K
96i sfon112s
13 Dec 22
Marker Therapeutics and Lincoln Park Capital Enter into a Common Stock Purchase Agreement for up to $25 Million
7:30am
8-K
oaoqm635r
22 Nov 22
Marker Therapeutics Announces FDA Clearance of IND for MT-601, its Six-Antigen T Cell Therapy for the Treatment of Pancreatic Cancer
7:15am
8-K
eljj4izc
10 Nov 22
Marker Therapeutics Reports Q3 2022 Operating and Financial Results
4:16pm
8-K
nrz266w3qqn
20 Oct 22
Termination of a Material Definitive Agreement
4:31pm
8-K
k149wy2cfgh
27 Sep 22
Departure of Directors or Certain Officers
8:45am
8-K
hvqbw0fnat0rn61fz28c
13 Sep 22
Marker Therapeutics Awarded $2 Million Grant from U.S. FDA to Support Marker’s Phase 2 ARTEMIS Trial of MT-401 in Post-Transplant AML
9:16am
8-K
i4jtfe
19 Aug 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
8:30am
8-K
9p23qag65hpqp 5i
11 Aug 22
Marker Therapeutics Reports Q2 2022 Operating and Financial Results
4:41pm
8-K
rl32um1
4 Aug 22
Company expects to initiate Phase 1 trial of MT-601 in r/r NHL in 2023
4:50pm
8-K
n2ch 9y3121ix
27 May 22
Amendments to Articles of Incorporation or Bylaws
4:06pm
8-K
ga5hgh 3t59
13 May 22
Marker Therapeutics Reports Q1 2022 Operating and Financial Results
7:11am
8-K
yli47 wlj
26 Apr 22
Marker Therapeutics Announces Entry into Services Agreement with Wilson Wolf
7:24am
8-K
pq1an77fxg
6 Apr 22
Departure of Directors or Certain Officers
4:08pm
8-K
xjnuh3ww2eu1mgeq tu
17 Mar 22
Marker Therapeutics Reports Fiscal Year 2021 Operating and Financial Results
6:21pm
8-K
zv9fe 6diea171ah
18 Feb 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:05pm